Alnylam Pharmaceuticals
ALNY
#728
Rank
S$43.74 B
Marketcap
S$326.91
Share price
2.55%
Change (1 day)
-43.27%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company